News

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, summarized its biomarker and translational data for pelareorep, the ...
Amino acids play a fundamental role in regulating how cells respond to drugs. These molecules, which form proteins, act like ...
Cullinan's innovative approach and Zipalertinib's potential approval in 2026 position it as a promising biotech investment.
Emerging research positions TUDCA, a bile acid compound, as a promising neuroprotective agent against Alzheimer’s, ...
Mesenchymal stem cell therapy lessens disability and brain lesions in MS patients, according to a review of published studies ...
Liver cancer is a malignant tumor characterized by high incidence and mortality rates worldwide. According to the report by the World Health Organization, ...
Piston Bio LLC, a biotechnology company developing both small molecules and biologics for the treatment of cancer, today announced that its scientific advisors have endorsed the potential of its ...
Psilocybin, the psychoactive compound found in 'magic' mushrooms, may help delay aging by increasing the cellular lifespan of ...
A study led by Prof. Liang Xingjie's team from the National Center for Nanoscience and Technology of the Chinese Academy of ...
Scientists identified the mechanism by which a sea cucumber molecule inhibits sulfatase-2, an enzyme that’s often upregulated ...
Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...
During early drug development and preclinical development, researchers use in vitro cultured lymphocytes to induce cytokine ...